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Summary 
Complexes of the milk protein, -lactalbumin, and the fatty acid, oleic acid, have 
previously been shown to be cytotoxic. Complexes of -lactalbumin and five different 
fatty acids (vaccenic, linoleic, palmitoleic, stearic and elaidic acid) were prepared and 
compared to those formed with oleic acid. All complexes were cytotoxic to human 
promyelocytic leukemia-derived (HL-60) cells but to different degrees depending on 
the fatty acid. The amount of fatty acid per -lactalbumin molecule was found to 
correlate with the cytotoxicity; the higher the number of fatty acids per protein, the 
more cytotoxic the complex.  Importantly, all the tested fatty acids were also found to 
be cytotoxic on their own in a concentration dependent manner. The cytotoxic effect 
of complexes between -lactalbumin and linoleic acid, vaccenic acid or oleic acid 
was further investigated using flow cytometry and found to induce cell death 
resembling apoptosis on Jurkat cells. 
Practical applications 
Cytotoxic complexes of α-lactalbumin and several different fatty acids could be 
produced. The cytotoxicity of all the variants is similar to that previously determined 
for α-lactalbumin/oleic acid complexes. 
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Introduction 
During the last decade, researchers have studied a cytotoxic complex consisting of the 
milk protein, alpha lactalbumin (-LA), and the fatty acid, oleic acid (OA). Such a 
compound, called HAMLET or BAMLET (Human/Bovine alpha lactalbumin made 
lethal to tumor cells), can be generated by addition of purified -LA to an anion 
exchange column pretreated with OA, followed by elution of the -LA:OA complex 
with a high salt buffer [1]. In order to generate the cytotoxic complex, the fatty acid 
was shown to be a required factor and for optimal cytotoxic effect, the fatty acid had 
to be either OA or vaccenic acid [2], suggesting that the apoptotic effect of the 
complex was sterio selective. 
HAMLET showed promising healing results in vivo when tested as topical application 
on human skin papillomas [3], on human glioblastoma xenografts in a rat model [4] 
and by intravesical HAMLET instillations in both mice and humans with bladder 
cancer [5, 6].  
In addition to human and bovine -LA, equine, caprine, and porcine -LA can also 
form cytotoxic complexes with OA [7]. Later investigations showed that the loss of 
tertiary structure in -LA denatured by heat-treatment or a recombinant variant of -
LA in which all four cysteines have been exchanged with alanine did not prevent it 
from forming cytotoxic complexes using an OA conditioned column [8, 9]. 
Furthermore, equine lysozyme, a structural homolog to -LA, can also be converted 
to a cytotoxic complex on an OA pretreated anion exchange column [10, 11]. 
Complexes between bovine β-lactoglobulin and OA have also been formed [12, 13]. 
In addition it was found that it is possible to make BAMLET-like complexes without 
the need for a pretreated anion-exchange column; Knyazeva et al. formed complexes 
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of α-LA and OA by titrating the protein solution with OA under alkali conditions 
[14]. Furthermore, complexes of peptide fragments of α-LA have been formed by 
mixing the protein with OA in ethanol dispersed in a buffer [15] and BAMLET has 
also been made by mixing α-LA with the more soluble sodium salt of OA, sodium 
oleate [16]. The -LA:OA complexes are cytotoxic to a wide range of cancer cells  
[17-19] as well as some types of primary cells [17]. The structure of the H/BAMLET 
has been a subject of multiple studies, often with conflicting results. The number of 
OA molecules bound to α-LA has reported values between 1 and 13 [2, 9, 14, 20]. 
A recent study showed that OA plays an essential role for the cytotoxicity of -
LA:OA complexes and that the cytotoxicity of OA alone is comparable to that of the 
-LA:OA complex in a concentration dependent manner [17]. Another study showed 
that the cytotoxicity of complex appears to depend entirely on the fatty acid 
component [12]. Fatty acids are cytotoxic on their own, but the sensitivity of different 
cell types to treatment with fatty acids differs with both the concentration and the type 
of fatty acid in question [21, 22]. Several mechanisms involved in the toxicity of fatty 
acids have been suggested. Examples are changes in mitochondrial transmembrane 
potential and intracellular neutral lipid accumulation [21], activation of caspase 3 and 
production of reactive oxygen species [23], as well as endpoints such as loss of 
membrane integrity and DNA fragmentation [24]. 
In the present study, complexes of -LA and fatty acids (-LA:FA complexes) were 
prepared as well as complexes with different amounts of fatty acids per protein in 
order to investigate the cytotoxicity of -LA in combination with different fatty acids. 
The fatty acids used were OA (18:1 cis Δ9), elaidic acid (EA, 18:1 trans Δ9), vaccenic 
acid (VA, 18:1 cis Δ11), palmitoleic acid (PA, 16:1 cis Δ9), linoleic acid (LA, 18:2 
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cis Δ9, Δ12) and stearic acid (SA, 18:0). The influence of the number of fatty acids 
per -LA molecule on the cytotoxicity was examined. In addition, the cytotoxicity of 
the fatty acids in the absence of -LA was investigated. Lastly, flow cytometric 
analysis was performed to assess the phosphatidylserine (PS) exposure and membrane 
permeability in response to treatment of Jurkat cells with the -LA:FA complexes. 
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Materials and Methods 
All buffers were prepared from analytical grade chemicals purchased from Sigma-
Aldrich (Brøndby, Denmark) or Merck (Hellerup, Denmark). Milk used for the 
purification of α-LA to make BAMLET was sourced from a local farm (Aarhus, 
Denmark). For the formation of the -LA:FA complexes in the single-phase system 
(see below), -LA (95% purity, 3% β-lactoglobulin content) was purchased from 
Davisco Foods International, Inc (Eden Prairie, MN, USA). The fatty acids and 
sodium derivates of the fatty acids were purchased from Nu-Chek Prep (Elysian, MN, 
USA) with the exception of sodium stearate and sodium oleate, which were purchased 
from Sigma Aldrich (Dublin, Ireland). Cell lines HL-60 (human promyelocytic 
leukemia-derived cell line, code ACC3) and Jurkat (human acute T cell leukemia-
derived cell line, code ACC 282) from Deutsche Sammlung von Mikroorganismen 
und Zellkulturen were used. 
 
Preparation of -LA:OA complexes by use of ion-exchange column 
-LA was purified from bovine milk and used for the preparation of BAMLET as 
previously described. [20]. In brief, -LA was purified by subjecting the whey 
fraction of bovine milk to two consecutive DEAE-Sepharose fast flow columns in the 
presence or absence of Ca
2+
 on the first and second column, respectively. The -LA-
containing fractions were pooled, lyophilized and stored at -20C until use.  
The purified -LA was used for the preparation of BAMLET [20]; a DEAE-
Sepharose fast flow column was pretreated with OA and unbound OA was removed 
from the column by washing with a high salt buffer (1 M NaCl, 10 mM Tris, pH 8). 
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-LA dissolved in buffer (10 mM Tris, 0.08 mM EDTA, pH 8.5) was added to the 
OA pretreated column. After removal of pure -LA with a low salt buffer (0.2 M 
NaCl, 10 mM Tris, pH 8.5), the -LA:OA complex was eluted using the high salt 
buffer (1 M NaCl, 10 mM Tris, pH 8). The eluate was dialyzed against 10 L 
phosphate buffered saline (PBS; 138 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 1.5 
mM KH2PO4, pH 7.4), and concentrated to approximately 2 mg/mL using an Amicon 
stirred cell with an Ultracell Amicon Ultrafiltration Disc membrane (MW cut-off = 
10,000 Da). The samples were frozen and kept at -20C until use. The protein content 
of the samples was determined by acid hydrolysis followed by quantitative amino acid 
analysis. The given concentrations of BAMLET are thus based on the -LA 
component alone. 
 
Preparation of -LA:FA complexes by single-phase system  
α-LA purchased from Davisco Foods International, Inc was further purified by ion-
exchange chromatography. Briefly, the powder was solubilized in 10 mM Tris-HCl, 
pH 7.0 and applied to a Q-Sepharose (GE Healthcare, Dublin, Ireland) ion-exchange 
column. The protein was eluted using a gradient from 0 to 1 M NaCl in 10 mM Tris-
HCl, pH 7.0. Fractions were collected and those containing only α-LA were pooled 
and dialyzed against distilled water before freeze-drying. SDS-PAGE analysis 
indicated the absence of any β-lactoglobulin impurity, therefore the final purity of α-
LA was greater than 98%. For preparation of the complexes, α-LA was solubilized in 
PBS overnight. The α-LA concentration was determined using absorbance at 280 nm 
and an extinction coefficient E1%, 280nm of 20.1. The α-LA solution was diluted to a 
concentration of 3 mg/mL (0.21 mM) and one of the salts of various fatty acids was 
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added: sodium oleate, sodium vaccinate, sodium linoleate, sodium elaidate, sodium 
palmitoleate, or sodium stearate. Three fatty acid concentrations were used: 0.42 mM, 
1.06 mM, and 2.11 mM corresponding to an initial molar ratio of 2, 5, and 10 fatty 
acid molecules per α-LA molecule. The mixtures (20 mL) were heated at 60°C for 1 
hour. The heated solutions were cooled on ice and dialyzed against distilled water at 
room temperature for 36 hours with three changes of water to remove unbound fatty 
acid and salt. The dialyzed solutions were freeze-dried. 
 
Dynamic light scattering 
The hydrodynamic radius of the aggregates formed in solutions containing the sodium 
salts of the fatty acids and in α-LA:sodium salt mixtures were measured using a Nano-
Zetasizer system (Malvern Instruments Inc., Worcestershire, UK). The measurements 
were made at 25°C at a scattering angle of 12º. The cumulative method was used to 
find the mean size of a particle that corresponded to the mean of the volume 
distribution. Given the low concentration of protein, the viscosity of the solution was 
assumed to be equal to that of water. 
 
Measurement of fatty acid content 
The amount of fatty acid added to the cells was quantified using a Free Fatty Acid 
Quantification assay (Biovison, Mountain View, CA, USA) according to the 
manufacturer’s instructions. In brief, the samples with unknown fatty acid content 
were added to the wells of a 96 well plate in several dilutions to make sure the fatty 
acid content falls within the standard curve prepared with known amounts of palmitic 
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acid. Fatty acid assay buffer was added to all wells to reach a final volume of 50 µL. 
In addition, 2 µL Acyl CoA synthetase were added to each well followed by 
incubation at 37C for 30 minutes to allow conversion of the fatty acids to their CoA 
derivatives. A mix of enzymes, enhancer and a fatty acid probe was added to each 
well resulting in oxidation of the CoA derivatives and generation of hydrogen 
peroxide as a side product. The fatty acid probe then reacts with the hydrogen 
peroxide and generates a red color during 30 minutes incubation at 37C in the dark. 
The color was detected at 570 nm using an ELISA plate reader. 
 
Cell culture 
HL60 and Jurkat cells were grown in the culture medium RPMI-1640 with glutamine 
(Gibco, Invitrogen, Taastrup, Denmark) supplemented with 10 mM HEPES, 23.8 mM 
NaHCO3, 10% heat treated fetal calf serum (FCS) (Gibco), 2 mM Glutamax (Gibco), 
60 µg/mL penicillin (Benzylpenicillin, Panpharma, Luitré, France) and 0.1 mg/mL 
streptomycin (Sigma). The cells were kept between 1x10
5–1.5x106 cells/mL.  
 
Measurement of Cytotoxic Activity  
To analyze the cytotoxic activity of the various compounds, i.e., fatty acids, -LA and 
-LA:FA complexes, an assay estimating cell viability by measuring the ATP content 
of the cells (CellTiter-Glo Luminescent cell viability assay, Promega) was used. 
HL-60 cells were harvested by centrifugation at 150g for 5 minutes, resuspended at 
2×10
5
 cells/mL in serum-free culture medium and seeded into 96-well plates with 50 
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µL cell suspension per well (1×10
4
 cells/well). HL-60 cells were chosen for the 
cytotoxicity experiments as they have been used as a reference cell line in an earlier 
study [17]. 
Lyophilized -LA or -LA:FA complexes to be used in the assays were dissolved in 
PBS before use. For investigation of the cytotoxicity of fatty acids alone, free fatty 
acids were dissolved in 96% ethanol and diluted three-fold in ethanol covering 100 
mg/mL to 0.14 mg/mL (350 mM - 500 µM). Each FA/ethanol dilution was 
subsequently diluted 100 times in PBS and the resulting dilutions were added to the 
cells (50 µL FA + 50 µL cells in serum free culture medium, final concentration 1777, 
592, 197, 65.8, 21.9, 7.31, 2.44 µM). Immediately before addition to the cells, the FA 
dilutions were sonicated for 5 minutes, which allowed for better dispersion of the FA 
and more reproducibility when aliquoting the FA. As controls 50 µL, of PBS and PBS 
+ 5 µL of lysis solution (Cytotoxicity Detection Kit
PLUS
 (LDH) from Roche) were 
added to cells in 50 µL culture medium. In all experiments, the cells and proteins or 
FA were incubated for 1 hour in cell culture medium without FCS in a humidified 5% 
CO2 atmosphere at 37C. After 1 hour, heat-inactivated FCS was added to all wells to 
reach 5% FCS followed by 3.5 hour incubation. After a total incubation time of 4.5 
hours the experiments were evaluated using the ATP assay as recommended by the 
manufacturer (CellTiter-Glo Luminescent cell viability assay) and the resulting 
luminescence was detected on a VICTOR
3
 1420 Multilabel Counter (PerkinElmer).  
The results presented are the average and standard deviation of two independent 
replicates with measurements on each replicate made in triplet. The LC50 was 
determined by fitting the data to a sigmoidal dose response curve using GraphPad 
Prism ® software (version 3.03, GraphPad Software Inc, La Jolla, CA, USA). 
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Analysis of variance (ANOVA) was carried out using SigmaStat (version3.0, Jandel 
Scientific, Corte Madera, CA, USA); the Student-Newman_Keuls method, pairwise 
multiple comparison procedures were used to determine differences between the 
LC50 of the different complexes and fatty acids. 
 
Flow Cytometry 
Cell death induced by -LA:FA complexes was investigated using Annexin V and 7-
Amino-actinomycin (7AAD) modified from the Annexin V/PI assay [25] as described 
previously [17]. Jurkat cells were harvested by centrifugation at 150g for 5 minutes 
followed by resuspension in serum free cell culture medium. A cell suspension of 
3.75×10
5
 cells/mL was prepared and 1 mL cell suspension was added to the wells of 6 
well plates (TPP tissue culture test plate 92006). Then 500 μL PBS or -LA:FA 
complex were added to the appropriate wells followed by incubation in a humidified 
5% CO2 atmosphere at 37C. After one hour, 75 µL heat inactivated FCS was added 
to reach a final concentration of 5% serum. Positive controls for necrosis and 
apoptosis were attained by heat-treatment for 30 minutes at 56C or by treatment with 
10 µM camptothecin for 4.5 hours, respectively. After a total incubation time of 4.5 
hours, the cells were washed two times in PBS and resuspended in Hanks Balanced 
Salt Solution (+Ca
2+
, +Mg
2+
). The cells were stained with Phycoerythrin (PE)-
conjugated Annexin V and 7-AAD (BD Biosciences, Annexin V-PE Apoptosis 
Detection kit I, 55976) using 5 µL Annexin V or 7AAD per 1x10
5
 cells in 100 µL 
buffer followed by 15 minutes incubation in the dark at room temperature before 
immediate analysis. The binding of Annexin V and 7AAD was investigated using a 
Cytomics FC 500 flow cytometer (Beckmann Coulter, FC 500 MCL System with 
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CXP Software) and a 488 nm argon laser for excitation. Annexin V-PE was detected 
in FL-2 by a 575 nm band pass filter, while 7AAD was detected in FL4 by a 675 nm 
band pass filter. Standard compensation using unstained and single stained cells was 
conducted in FlowJo Flow Cytometry Analysis Software (Tree Star, Inc.). For each 
sample, 7,500 cells were analyzed and the double negative (Annexin V
-
, 7AAD
-
), 
single positive cells (Annexin V
+
, 7AAD
-
) and double positive cells (Annexin V
+
, 
7AAD
+
) were expressed as a percentage of the total cell number. 
Results 
Complexes between -LA and the following six fatty acids; OA, EA, SA, VA, PA 
and LA were prepared according to a previously established method, using a single 
phase system [16]. The low solubility of the fatty acids in aqueous systems can limit 
its application. However, this problem could be overcome by heating the more soluble 
fatty acid salts in the presence of the protein (60°C). 
Dynamic light scattering measurements at 25°C prior to heating the mixtures, showed 
that the presence of α-LA broke-up the large aggregates formed by the fatty acid salts 
in solution. The size of the particles present in the fatty acid solution was distributed 
in a trimodal manner in the absence of α-LA (Fig. 1A, C, E, G). In the presence of α-
LA, the mixture took on a monomodal size distribution (Fig. 2B, D, F, H). The size of 
the particles present was slightly larger than that of an α-LA solution, 3.5 nm (not 
shown). The disappearance of the large fatty acid aggregates indicates the possible 
formation of a complex between α-LA and fatty acids. The sodium elaidate and 
sodium stearate were insoluble at room temperature making any meaningful dynamic 
light scattering measurements impossible; however, the addition of the protein greatly 
increased the solubility of these fatty acids.  
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The results outlined here show that the previously used single-phase system used for 
complex preparation was successfully employed to form complexes with a variety of 
fatty acids. While ratios of 2, 5, and 10 fatty acids per α-LA were used when 
preparing the complexes, not all the fatty acid bound to α-LA. The extensive dialysis 
step in the preparation removed the unbound fatty acid [16]. The binding 
stoichiometry was dependant on the initial quantity of fatty acid present. The variation 
in the quantities of the various fatty acids bound was low, on average approximately 
50 % of the fatty acid added was bound to the protein after the dialysis step. The 
values for stoichiometry of complexes are shown in table 1. 
Cytotoxicity of -LA/FA complexes 
All six complexes were found to be cytotoxic to HL-60 cells with a 50% loss of 
viability (LC50) at 17 ± 2, 25 ±1, 26 ± 1, 28 ± 2, 239 ± 4 and 294 ± 11 µM fatty acid 
in complexes of -LA and VA, PA, LA, OA, EA and SA respectively, thus resulting 
in a difference between the most cytotoxic (-LA:VA) and the least cytotoxic 
complex (-LA:SA) of approximately 17 fold (Fig. 2). The differences between the 
VA, PA, LA and OA complexes were not significant however, the SA and EA 
complexes were significantly less cytotoxic that the others (P<0.05).   
 
Influence of the amount of fatty acid on the cytotoxicity of the -LA:FA complexes 
The influence of the number of fatty acid per -LA molecule on the cytotoxicity was 
investigated for complexes between -LA and LA, VA and OA. A correlation was 
seen between the cytotoxicity and the -LA:FA ratio, i.e., more fatty acid per -LA 
results in higher cytotoxicity (Fig. 3). The cytotoxicity of BAMLET prepared on the 
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OA-pretreated ion chromatography column with a final -LA:OA ratio of 1:6.1 was 
very similar to that of the -LA:OA complex with a final ratio of 1:5.7 prepared by 
heating mixtures of sodium oleate and -LA followed by heating (Fig. 3A). 
 
Cytotoxicity of various fatty acids 
The cytotoxicity of the various fatty acids alone was investigated using HL-60 cells 
and the ATP assay. All tested fatty acids were cytotoxic as illustrated in Fig. 4. LA, 
PA, VA and OA had very similar cytotoxicities. EA showed the least cytotoxic 
activity. It was not possible to investigate the cytotoxicity of SA under the 
experimental conditions used here, as the melting point for stearic acid is 69-70C 
[26]. The measured fatty acid concentration in the cell media was lower than 
theoretically calculated, probably due to loss of FA to plastic surfaces of tubes 
(eppendorpf tubes) and pipette tips. The amount of FA used in this assay was 
measured using a fatty acid quantification kit and the measured FA concentration is 
depicted on the x-axis in Fig. 4.  The LC50 of the fatty acids was 5 ± 1, 5 ± 1, 8 ± 1, 9 
± 1, and 896 ± 1 μM for LA, PA, VA, OA and EA respectively. EA is significantly 
(P<0.05) less cytotoxic than the other fatty acids. 
 
Flow cytometry analysis of cell death induced by -LA:FA complexes 
To further investigate cell death induced by the various -LA:FA complexes, Jurkat 
cells treated with complexes between -LA and VA, LA, or OA were analyzed by 
flow cytometry using Annexin V and 7AAD. Jurkat cells were chosen over HL-60 
cells in these experiments as the incubation time with camptothecin required to obtain 
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a positive control for apoptosis for HL-60 cells (>12 hours) exceeded the duration of 
the experiment (4.5 hours). Exposure of PS on the outer leaflet of the plasma 
membrane indicative of cell death resembling apoptosis was detected by Annexin V 
binding. Membrane damage indicative of necrosis or late apoptosis was detected by 
staining with the DNA intercalating dye, 7AAD. As illustrated in Fig. 5., the three 
types of complexes tested (-LA:LA, -LA:VA, and -LA:OA) all resulted in an 
increase in Annexin V positive and 7AAD negative cells (Annexin V
+
, 7AAD
-
) from 
1% for untreated cells to 12.9%, 21.2% and 21.5% for cell treated with the three 
complex-types, respectively. A slight increase in double positive cells (Annexin V
+
, 
7AAD
+
) was also seen for the complexes from 0.57% for untreated cells to 2.44%, 
3.04% and 6.76% for cell treated with -LA:LA, -LA:VA and -LA:OA, 
respectively (Fig. 5D-F). As seen in Fig. 5G and 5I, cells treated with 75 µg/mL -
LA:LA complex closely resembled untreated cells, whereas treatment with 125 
µg/mL -LA:LA complex resulted in loss of cells manifested as a low number of 
events counted during flow cytometry. 
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Discussion 
Two different methods were used for the preparation of complexes for this study. 
BAMLET complex was prepared using the well-established chromatographic method 
[1]. While this method has some shortcomings in terms of lab-to-lab reproducibility it 
is the method that has been used for the majority of studies involving H/BAMLET in 
the literature. Therefore it is beneficial to use BAMLET for comparative purposes.  
In the present study, complexes containing OA, EA, VA, PA, LA and SA were 
produced by mixing the sodium salts of the fatty acids with α-LA followed by heating 
at 60°C. Several variations of this approach had been employed previously to make 
BAMLET-like complexes [12-15]. Excess fatty acid was removed by extensive 
dialysis of the complex. The formation of BAMLET either by a chromatographic or 
mixing method is not fully understood. Recent studies have shown that large 
quantities of oleate can associate with α-LA [27]; however, the quantities of oleate 
which have been reported in BAMLET complexes are much lower. This suggests that 
some of the FA may be only loosely associated with α-LA and may be removed by 
dialysis. If there is an equilibrium between bound and free FA in the complex, it could 
be expected that if the dialysis is sufficient, all bound FA could be removed. In light 
of these unknown binding mechanisms, the dialysis was carefully carried-out to 
standardize the way each preparation was treated and to eliminate any differences due 
to the treatment during the dialysis step. 
We show here that complexes between -LA and different fatty acids with varying 
degrees of saturation and double bond conformation are also cytotoxic (Fig. 2). The 
order of cytotoxicity was -LA:VA = -LA:LA = –LA:OA = -LA:PA > -LA:EA 
> -LA:SA with a difference in LC50 of approximately 17 fold between the most (-
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LA:VA and -LA:PA LC50 = 17 µM fatty acid) and the least (-LA:SA LC50 = 294 
µM fatty acid) cytotoxic complex. 
Earlier reports have suggested that only OA and VA are optimal for formation of a 
cytotoxic complex on a column pretreated with the fatty acid in question [2]. While 
other unsaturated cis fatty acids were shown to form complexes with -LA, the yield 
of complex formation was lower and the complexes had suboptimal cytotoxicity [2].  
There may be some possible explanations for the difference in results observed here 
compared to this previous study. It was suggested that the interaction between the 
fatty acids and α-LA was stereo-specific favoring the cis conformation. However, in 
the present study, complexes with EA and SA, which are both trans fatty acids, were 
successfully formed. The suggested stereo-specific interactions may play a role in 
how the fatty acids bind to the column matrix and how they are “presented” on the 
matrix to be available for the protein. As an ion-exchange resin was used for the 
preparation in the previous study, the pKa of the fatty acid may affect its interaction 
with the column. As both chain length and conformation of the fatty acids influence 
the pKa, the interaction with the column and possible association with α-LA may 
differ between various fatty acids. The method employed for preparation of the 
complexes in this study is more straightforward as any influence of the interaction of 
the fatty acids with the column is removed, and the complex formation is solely 
dependent on the interactions between the fatty acid and the protein. The equilibrium 
between a-LA and fatty acid is further complicated by the equilibrium between the 
fatty acid and column matrix. As the binding to α-LA has been reported to be quite 
weak [28], the absorption onto the column matrix may in fact limit the amount of fatty 
acid taken up by the protein. The variations in the affinity of different fatty acids for 
the column matrix and/or α-LA could be significant in the formation of the complexes 
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using the column method. However, as can be seen in Figure 1, the fatty acid readily 
associates with the protein when they are in solution together. The earlier study [2] 
did not determine the amount of fatty acid bound to the column matrix. It is thus 
possible that this is where the variation in the yields of the different complexes could 
have arisen.  The different preparation methods may offer an explanation for the 
discrepancies between the results obtained here and the previous study. 
In previous studies, the quantification of the concentration of complex used for 
cytotoxicity assays was based solely on the protein concentration, whereas the crucial 
measure of the fatty acid component of the complex was not made. Recent studies 
have shown that the fatty acid (OA) portion is the cytotoxic component of the 
complex [12], meaning that using a fixed concentration based on protein content may 
not be an adequate approach when determining cytotoxicity. The steep dose response 
curves observed here (Fig. 2.) imply that a small difference in the amount of fatty acid 
bound to α-LA could induce a difference between ~100% and ~0% viability of the 
cells in the presence of a fixed protein concentration. Thus it is crucial to measure the 
fatty acid content in order to compare the cytotoxicity of different complexes. 
The dynamic light scattering measurements show that PA, VA and LA salts behave in 
a manner similar to sodium oleate when in solution with α-LA; a further indication 
that the approach described here is suitable for the formation of complexes for a 
variety of different fatty acids.  The results show that there is an interaction between 
the fatty acid and the protein even prior to heating the solution. This agrees with 
previous studies where a decrease in particle size and/or turbidity was observed when 
OA was mixed with α-LA [15, 29]. While dynamic light scattering data for SA and 
EA salts was not included because of their insolubility, it is clear from the results for 
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the other fatty acids that α-LA greatly increases the solubility of the fatty acid salts. 
Thus, it is likely that -LA had the same effect on the SA and EA salts. Visually, the 
solubility of the two salts seemed to increase greatly in the presence of -LA. 
HAMLET has been shown to translocate across the plasma membrane and into the 
nucleus of cancer cells [4, 30], where it interacts with the histones and perturbs the 
chromatin structure [30]. HAMLET has also been shown to affect mitochondria [31] 
and induce apoptosis-like cell death with caspase activation, PS externalization and 
chromatin condensation irrespective of the p53 and bcl-2 status of the cells [32] and to 
cause changes in proteasome structure and function [33]. In addition, it has been 
shown by Aits et al. that HAMLET induces autophagy [34], while Rammer et al. see 
activation of the lysosomal death pathway in response to BAMLET treatment, but that 
the cytotoxicity of BAMLET does not depend on autophagy [18]. However, apart 
from these quite specific effects of HAMLET, there is also evidence of a more crude 
effect connected to membrane interactions and alterations. -LA binds to the 
membrane, but HAMLET causes loss of membrane integrity and leakage of lipid 
membranes [35] and ELOA, the cytotoxic complex between equine lysozyme and 
OA, has also been shown to induce loss of membrane integrity with ELOA 
accumulating at the cell membrane until the cells rupture and ELOA fills the cells [11, 
36].  
Several reports show that fatty acids cause loss of membrane integrity in higher 
concentrations [21, 23, 24], which could indicate that the fatty acid in itself is 
responsible at least for the membrane-altering effects of -LA:FA complexes. 
When investigating the cytotoxicity of the -LA:FA complexes, it was found that the 
concentration range between no measurable response and 100% cell death was very 
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narrow (Fig. 1 and 3). The ATP assay used in this report does not discriminate 
between direct lysis of the cells and induction of cell death followed later by loss of 
membrane integrity. However, the results shown in Fig. 5 demonstrate the existence 
of cells with PS exposure but without loss of membrane integrity, indicative of 
induction of cell death rather than direct lysis. Nevertheless, as Fig. 5 illustrates, there 
is a very narrow concentration range (e.g., 75–125 µM for -LA:LA) between no 
detectable effect and the loss of membrane integrity or even loss of intact cells as seen 
by the low cell numbers detected by the flow cytometer (Fig. 5G to I). This narrow 
concentration range was also seen for -LA:VA and -LA:OA complexes (data not 
shown).  
By preparing complexes of -LA and LA, VA or OA in different -LA:FA ratios, it 
was found that the cytotoxicity of the complexes was correlated to the number of fatty 
acid per protein with more fatty acids per protein being more cytotoxic (Fig. 3).  
When BAMLET, prepared on the OA pretreated ion exchange column as described in 
this paper, is compared to HAMLET and BAMLET prepared according to Svanborg 
et al. [1], the complexes show similar cytotoxicity [17]. As illustrated in Fig. 3, the 
cytotoxicity of BAMLET (-LA:OA = 1:6.2) was also comparable to that of the -
LA:OA complex prepared with the single-phase system resulting in a -LA:OA ratio 
of 1:5.7 (Fig. 3A). Together this indicates that the fatty acids play a crucial role in the 
cytotoxicity of HAMLET and BAMLET-like complexes. Furthermore, the 
comparability of the various complexes underlines that the cytotoxic complexes can 
be prepared using different methods as also shown by Permyakov [37].  
Some of the free fatty acids seem to be more cytotoxic than their corresponding 
complexes. Earlier reports on H/BAMLET and other -LA:FA complexes did not 
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find fatty acids to be cytotoxic in the concentrations present in the complexes [1, 2, 
15].  However a recent study suggested that the amount of fatty acid delivered to the 
cells may be greatly reduced due to adsorption of the fatty acids on the surfaces of 
plastics meaning that the reported LC50 of the fatty acids may have been over-
estimated previously; this may explain the apparent discrepancies in the literature 
regarding the cytotoxicity of OA [17]. In the present study great care was taken in 
solubilising the fatty acids by dissolving them in ethanol and subjecting them to 
sonication; this may aid in increasing their cytotoxicity. It is worth noting that the 
cytoxicity of elaidic acid increased greatly when it was in complex, there is a nearly 6 
fold reduction in the LC50 of the fatty acid when in complex compared to the free fatty 
acid. Elaidic acid was one of the least soluble fatty acids used for this study so it is 
hardly surprising that its cytotoxic activity showed the greatest increase when in 
complex with α-LA. From both the results with the free fatty acid and the complexes, 
it can be seen that the type of fatty acid may be significant in terms of the cytotoxic 
effect. The cis fatty acids were all grouped together with little or no differences in 
their cytotoxicty, the trans fatty acids (elaidic and stearic) were significantly less 
cytotoxic that the cis fatty acids. The poor solubility of the trans fatty acids could be a 
contributing factor here. 
These results raise questions about the benefit of delivering the fatty acids in a 
complex with α-LA. Further studies are required to evaluate the stability and 
cytotoxicity of the complexes over time versus the solubilised fatty acids over time. 
The molar concentration of fatty acid present is the critical factor in determining the 
cytotoxicity, however, how the fatty acid is solubilised will also play a role. It could 
be expected that too high concentrations of the fatty acids would be less soluble and 
may not be as effective. To this end the CMC of the fatty acids may also be an 
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important factor in determining cytotoxicity, further studies into the behaviour of the 
fatty acids in cell culture media is required to determine whether this is the case. 
Forming a complex between the fatty acids and α-LA may be a more efficient means 
of solubilising the fatty acid and thus lead to more reproducible results. The strength 
of any association of fatty acid with the protein has to be sufficiently weak to allow 
the fatty acid be released from the protein to have a cytotoxic effect. Previous values 
reported in the literature would indicate that the association constant of OA to α-LA is 
relatively weak [28].  
It is becoming increasingly accepted that the cytotoxic component of the H/BAMLET 
complex is the oleic acid portion, but the present study shows that other fatty acids 
may be just as adequate. Importantly the cytotoxicity is related to the number of fatty 
acid molecules bound to the protein. 
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Figure legends 
Table 1. The quantity of fatty acid remaining in complex with α-lactalbumin after 
dialysis of the heated mixtures. 
 
Figure 1. Dynamic light scattering measurements on the sodium salts of fatty acids. 
Measurements of 1.06 mM Oleic acid (A, B), Vaccenic acid (C, D), Palmitoleic acid 
(E, F) or Linoleic acid (G, H) sodium salts in PBS solution. The distributions shown 
in panels B, D, F, and H were in the presence of 30 g/L α-LA. Measurements were 
carried out at 25°C. The x-axis shows the hydrodynamic radii of the particles. The y-
axis shows the distribution of the particles as a percentage based on their volume. 
 
Figure 2: -LA/FA complexes cytotoxixity  
The effect of the complexes between -LA and the six different fatty acids on HL-60 
viability was measured by the ATP assay. The FA acid concentration, measured using 
assay, applied to the cells is on the x-axis. The values on the y-axis are given as a 
percentage of the ATP signal of control cells treated with PBS. The experiment was 
performed in duplicate and the mean and standard deviation is shown for each 
concentration. vaccenic acid n , linoleic acid  , palmitoleic acid  , oleic acid l , 
elaidic acid u , stearic acid × . The data shown represents the mean and standard 
deviation of three independent replicates. 
 
Figure 3: Cytotoxicity of α-LA/FA complexes containing differing ratios of FAs 
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The cytotoxicity towards HL-60 cells by -LA:LA, -LA:VA and -LA:OA 
complexes with different -LA:FA ratios were measured with the ATP assay after 
incubation for 4.5 h. A) -LA:OA complexes 1:0.9 l , 1:1.4 n  & 1:5.7   and 
BAMLET 1:6.2 ; B) -LA:VA complexes 1:0.84 l , 1:3.1 n  & 1:6.2  ; C) -
LA:LA complexes 1:0.8 l , 1:2.05 n  & 1:6.3  . Each experiment was performed in 
triplicate and mean and standard deviation is shown for each point. 
 
Figure 4 Cytotoxicity of the fatty acids used to prepare the complexes 
The effect of elaidic  , vacceinc  ,, linoleic  , palmitoleic ×  and oleic n  acids on 
HL-60 viability was measured by the ATP assay. The actual fatty acid concentration 
applied to the cells was determined using a fatty acid quantification assay to quantify 
the fatty acid concentration present in the cell culture media. The values on the y-axis 
are given as a percentage of the ATP signal of control cells treated with PBS. The 
experiment was performed in duplicate and the mean and standard deviation is shown 
for each concentration. 
 
Figure 5: Flow cytometry analysis of the cytotoxicity of complexes between -LA 
and VA, LA or OA  
Flow cytometry analysis of PS exposure and membrane permeability using Annexin 
V-PE and 7AAD. Jurkat cells were incubated with camptothecin, PBS or complexes 
between -LA and LA, VA or OA, for 4.5 hours before flow cytometry analysis. A: 
Untreated cells (PBS). B: 10 µM camptothecin (positive control for PS exposure). C: 
heat treatment of the cells (56°C for 30 minutes) (positive control for membrane 
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permeability). D: -LA:LA treated cells (100 µg/mL). E: -LA:VA treated cells (75 
µg/mL). F: -LA:OA treated cells (200 µg/mL). G-I: Jurkat cells treated with 
increasing concentrations of -LA:LA. The experiment was repeated three times and 
the results shown are representative. For each sample, 7,500 cells were analyzed, 
except for (I) where only 403 cells were analyzed due cell loss. 
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Table 1, Brinkmann et al. 
 
Initial molar 
ratio 
Molar ratio 
after dialysis 
Binding 
efficiency 
Oleic Acid   
2 0.9 45 % 
5 1.4 28 % 
10 5.7 57 % 
BAMLET 6.2 N.A. 
Vaccinic acid   
2 0.84 42 % 
5 3.1 62 % 
10 6.2 62 % 
Linoleic acid   
2 0.8 40 % 
5 2.05 41 % 
10 6.3 63 % 
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Figure 1, Brinkmann et al. 
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Figure 2, Brinkmann et al. 
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Figure 3, Brinkmann et al. 
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Figure 4, Brinkmann et al. 
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Figure 5, Brinkmann et al. 
 
 
 
 
 
 
 
 
 
